Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • ANGUS D
    • KAYSON E
    • OAKES D
    • ROSAS HD
    • VAUGHAN C
    • PANEGYRES PK
    • PROF David Ames
    • DR Anita Goh
    • AGARWAL P
    • CHURCHYARD A
    • MURATHODIZIC M
    • HERD C
    • CHUA P
    • GERMAINE D
    • LIM L
    • MACK H
    • LOY C
    • GRIFFITH J
    • MITCHELL P
    • COREY-BLOOM J
    • GLUHM S
    • GOLDSTEIN J
    • STONE C
    • LEVI L
    • MARGOLIS R
    • YORITOMO N
    • JANICKI S
    • MARDER K
    • CLOUSE R
    • SINGER C
    • MOORE H
    • PADRON N
    • KOSTYK S
    • STOUT J
    • DALEY A
    • SEGRO V
    • KUMAR R
    • ANDERSON K
    • DRAZINIC C
    • HENNIG B
    • NANCE M
    • MOLHO E
    • CRISWELL S
    • LEDOUX MS
    • WIELER M
    • GUYOT S
    • IANNACCONE A
    • JENNINGS B
    • LEAVITT BR
    • FEIGIN A
    • EVANS S
    • WRAY S
    • CASACELI C
    • ORME C
    • GAO S
    • REILMANN R
    • WATTS A
    • BAKER K
    • LABUSCHAGNE I
    • EL-DAIRI M
    • FEKRAT S
    • HERSCH S
    • MOSCOVITCH-LOPATIN M
    • TANZI R
    • TARGUM S
    • RITCHIE CW
    • DORSEY ER
    • HELLES K

Published in

  • The Lancet Neurology

Time

Date/time value

  • 2015

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1474-4422(14)70262-5

Additional Document Info

Parent Title

  • LANCET NEUROLOGY

Volume

  • 14

Issue

  • 1

Publisher

  • The Lancet Publishing Group